Immix Biopharma, Inc–a clinical-stage biopharmaceutical company developing next-generation cancer therapies–announced today that it received a letter from the FDA authorizing it to proceed with expanding its phase 1b/2a clinical...
After three decades as an oncology nurse, Janet Soboleski, BSN, RN, OCN, knows that while different cancers have different symptoms and prognoses, virtually all cancer patients experience...
Seattle Genetics, Inc. (Nasdaq: SGEN) today announced the pricing of an underwritten public offering of 7,142,858 shares of its common stock at a price to the public...
Healthcare providers are focused on delivering care. That means always seeking better ways to improve patient outcomes, make reporting easier, and meet financial goals. It’s a...
Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved HADLIMA™ (adalimumab-bwwd), a biosimilar referencing HUMIRA® i (adalimumab), for the treatment of rheumatoid arthritis,...
Ra Pharmaceuticals, Inc. (Nasdaq: RARX) (“Ra Pharma”) today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock, at a public offering...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 29, 2019. Second Quarter 2019...
The acquisition of Insitumed will help Key Surgical to expand its portfolio of endoscopy products, in addition to further extending its global footprint. Key Surgical, which...
Technology for social good start-ups specialising in energytech, healthtech and envirotech pitched their innovations at the Unbound London festival. From 3D-printed braces for disabled children to...
NorthStar Medical Radioisotopes, a producer and distributor of radioisotopes for medical imaging, has secured $15m (£12m) funding in a cooperative agreement with the US Department of...
EBR Systems said that the College of the French National Authority for Health (Haute Autorite de Sante, HAS) awarded a Forfait Innovation Package for the company’s...
Target Audience and Goal Statements: Endocrinologists, oncologists, nuclear medicine specialists, internists, primary care physicians, surgeons, family medicine specialists The goal of one study was to determine...
Masimo announced today that in a study recently published in Anesthesia & Analgesia, researchers evaluated the ability of noninvasive and continuous hemoglobin monitoring with Masimo SpHb...
Sky Medical Technology (Sky) neuromuscular stimulation device, the geko, has seen the company secure a recent nomination at the Spectator’s 2019 Economic Disruptor Awards. The awards...
Medical device company Flow Neuroscience, creator of the Flow headset and therapy app for depression treatment, today announced it has raised $1.5m in an investment round....
Copyright © 2024 Medical Buyer